Remove Bioinformatics Remove Development Remove Reagent
article thumbnail

Tackling the Challenges of Limited Resources During a Pandemic

The Pharma Data

The Challenge: The demands of many labs simultaneously beginning COVID-19 screening programs are leading to a scarcity of resources like pipette tips and reagents. delays where reagents are in. Bioinformatics in the Faculty. use and development of proteomic methods to. In the examples below, we. The MANTIS. short supply.

Reagent 52
article thumbnail

Spatial Genomics, Transcriptomics and Proteomics Solutions – An Amelioration of Tissue Analytics

Roots Analysis

Recent advances in multi-omics approaches, including genomics, transcriptomics, proteomics, metabolomics, cytometry and imaging, in combination with bioinformatics and biostatistics, have been translated into several popular bioanalytical platforms, such as next-generation sequencing (NGS), single-cell analysis, flow cytometry and mass spectrometry.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Can Rapid mRNA Quantification Enhance Multivalent Vaccine Development?

XTalks

Erica Dawson Chief Research and Development Officer InDevR In this Xtalks Spotlight interview, Dr. Erica Dawson, Chief Research and Development Officer at InDevR, shared her insights on the current landscape of mRNA analytics and the potential breakthroughs that could support the future of multivalent vaccine development.

article thumbnail

Emerging Trends in Protein Expression Systems: Growth Opportunities And Future Outlook

Roots Analysis

Recent protein expression market trends showcase a growing emphasis on cell free protein expression systems, advanced bioinformatics, and the rise of the protein expression market for kits and reagents. However, the protein expression industry is not without substantial restraints which hinder its growth.

Protein 40